463 related articles for article (PubMed ID: 22795319)
21. Effect of dietary monosodium glutamate on HFCS-induced hepatic steatosis: expression profiles in the liver and visceral fat.
Collison KS; Maqbool ZM; Inglis AL; Makhoul NJ; Saleh SM; Bakheet RH; Al-Johi MA; Al-Rabiah RK; Zaidi MZ; Al-Mohanna FA
Obesity (Silver Spring); 2010 Jun; 18(6):1122-34. PubMed ID: 20111022
[TBL] [Abstract][Full Text] [Related]
22. Physiological handling of dietary fructose-containing sugars: implications for health.
Campos VC; Tappy L
Int J Obes (Lond); 2016 Mar; 40 Suppl 1():S6-11. PubMed ID: 27001645
[TBL] [Abstract][Full Text] [Related]
23. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease.
Softic S; Cohen DE; Kahn CR
Dig Dis Sci; 2016 May; 61(5):1282-93. PubMed ID: 26856717
[TBL] [Abstract][Full Text] [Related]
24. Adverse effects of dietary fructose.
Gaby AR
Altern Med Rev; 2005 Dec; 10(4):294-306. PubMed ID: 16366738
[TBL] [Abstract][Full Text] [Related]
25. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease.
Moore JB; Gunn PJ; Fielding BA
Nutrients; 2014 Dec; 6(12):5679-703. PubMed ID: 25514388
[TBL] [Abstract][Full Text] [Related]
26. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.
Geidl-Flueck B; Hochuli M; Németh Á; Eberl A; Derron N; Köfeler HC; Tappy L; Berneis K; Spinas GA; Gerber PA
J Hepatol; 2021 Jul; 75(1):46-54. PubMed ID: 33684506
[TBL] [Abstract][Full Text] [Related]
27. Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity.
Valle M; St-Pierre P; Pilon G; Marette A
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751772
[TBL] [Abstract][Full Text] [Related]
28. Fructose-mediated effects on gene expression and epigenetic mechanisms associated with NAFLD pathogenesis.
DiStefano JK
Cell Mol Life Sci; 2020 Jun; 77(11):2079-2090. PubMed ID: 31760464
[TBL] [Abstract][Full Text] [Related]
29. The role of the lipogenic pathway in the development of hepatic steatosis.
Postic C; Girard J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):643-8. PubMed ID: 19195625
[TBL] [Abstract][Full Text] [Related]
30. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
Byrne CD
Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
[TBL] [Abstract][Full Text] [Related]
31. Effects of fructose and glucose overfeeding on hepatic insulin sensitivity and intrahepatic lipids in healthy humans.
Lecoultre V; Egli L; Carrel G; Theytaz F; Kreis R; Schneiter P; Boss A; Zwygart K; Lê KA; Bortolotti M; Boesch C; Tappy L
Obesity (Silver Spring); 2013 Apr; 21(4):782-5. PubMed ID: 23512506
[TBL] [Abstract][Full Text] [Related]
32. The establishment of a novel non-alcoholic steatohepatitis model accompanied with obesity and insulin resistance in mice.
Cong WN; Tao RY; Tian JY; Liu GT; Ye F
Life Sci; 2008 May; 82(19-20):983-90. PubMed ID: 18417155
[TBL] [Abstract][Full Text] [Related]
33. Effect of trans-fat, fructose and monosodium glutamate feeding on feline weight gain, adiposity, insulin sensitivity, adipokine and lipid profile.
Collison KS; Zaidi MZ; Saleh SM; Inglis A; Mondreal R; Makhoul NJ; Bakheet R; Burrows J; Milgram NW; Al-Mohanna FA
Br J Nutr; 2011 Jul; 106(2):218-26. PubMed ID: 21429276
[TBL] [Abstract][Full Text] [Related]
34. Non-alcoholic fatty liver disease impairs hippocampal-dependent memory in male rats.
Ross AP; Bruggeman EC; Kasumu AW; Mielke JG; Parent MB
Physiol Behav; 2012 May; 106(2):133-41. PubMed ID: 22280920
[TBL] [Abstract][Full Text] [Related]
35. Sugar consumption, metabolic disease and obesity: The state of the controversy.
Stanhope KL
Crit Rev Clin Lab Sci; 2016; 53(1):52-67. PubMed ID: 26376619
[TBL] [Abstract][Full Text] [Related]
36. Dietary omega-3 fatty acid deficiency and high fructose intake in the development of metabolic syndrome, brain metabolic abnormalities, and non-alcoholic fatty liver disease.
Simopoulos AP
Nutrients; 2013 Jul; 5(8):2901-23. PubMed ID: 23896654
[TBL] [Abstract][Full Text] [Related]
37. Phenotyping the effect of diet on non-alcoholic fatty liver disease.
de Wit NJ; Afman LA; Mensink M; Müller M
J Hepatol; 2012 Dec; 57(6):1370-3. PubMed ID: 22796155
[TBL] [Abstract][Full Text] [Related]
38. GLP-1 receptor agonism ameliorates hepatic VLDL overproduction and de novo lipogenesis in insulin resistance.
Taher J; Baker CL; Cuizon C; Masoudpour H; Zhang R; Farr S; Naples M; Bourdon C; Pausova Z; Adeli K
Mol Metab; 2014 Dec; 3(9):823-33. PubMed ID: 25506548
[TBL] [Abstract][Full Text] [Related]
39. Metabolic effects of fructose and the worldwide increase in obesity.
Tappy L; Lê KA
Physiol Rev; 2010 Jan; 90(1):23-46. PubMed ID: 20086073
[TBL] [Abstract][Full Text] [Related]
40. Effects of short-term overfeeding with fructose, fat and fructose plus fat on plasma and hepatic lipids in healthy men.
Sobrecases H; Lê KA; Bortolotti M; Schneiter P; Ith M; Kreis R; Boesch C; Tappy L
Diabetes Metab; 2010 Jun; 36(3):244-6. PubMed ID: 20483648
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
